Teacher Beats Cancer, Celebrates 10 Years Remission

Amy Cheese was carrying a grapefruit-sized tumor pressing against her heart when doctors told her she had months to live.

The third-grade teacher from Colorado had exhausted every traditional treatment option for her lymphoma, a deadly form of blood cancer. In 2016, she traveled to the Fred and Pamela Buffett Cancer Center in Omaha, Nebraska, as a last resort to join an experimental immunotherapy trial.

Cheese became one of the first patients at the facility to receive CAR T-cell therapy. The groundbreaking procedure involved extracting her own immune cells, genetically reprogramming them to recognize and attack cancer, then returning them to her body to hunt down the disease.

She explained the complex science to her young students in simple terms: doctors turned her white blood cells into cancer-eating lions. Within months of the treatment, scans showed the tumor had completely disappeared.

Ten years later, Cheese remains in complete remission. She retired from teaching last year and now spends her days with her grandchildren, celebrating a future she once thought impossible.

Why This Inspires

Dr. Julie Vose, the hematologist and oncologist who treated Cheese, says seeing profound success in early trials remains deeply gratifying for medical teams pioneering cellular therapy. Dr. Matt Lunning, medical director of gene and cellular therapy at the center, notes that early trials conducted without decades of historical data helped transform CAR T-cell therapy from cutting-edge experiment into reliable standard care.

What started as a desperate gamble for patients like Cheese is now changing the landscape of cancer treatment. The therapy has evolved from an experimental last resort into an approved treatment option that gives hope to thousands of blood cancer patients each year.

On Friday, colleagues at Nebraska Medicine and the University of Nebraska Medical Center will gather to celebrate the patients, breakthroughs, and medical advances achieved through CAR T-cell therapy over the past decade. Cheese's story anchors those celebrations as living proof that today's experimental treatments can become tomorrow's miracle cures.

Her decade of remission represents more than one teacher's survival story. It marks a turning point in how medicine fights cancer, transforming the body's own immune system into a precision weapon against disease.